Posts Tagged biib

Opportunity Knocks: Turning Around 3 Large Biotechs (AMGN, BIIB, GENZ)

Biotech is the land of promise for emerging biotech players.  It is also the land of stagnation for well established and sturdy biotech giants once their growth models have come to fruition.  Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc. (NASDAQ: BIIB), and Genzyme Corp.

Tags: , , , , , , , ,

No Comments

Top 10 Analyst Upgrades and Downgrades (ABT, ARO, BIIB, CELG, CADC, FACT, HBC, LMNX, EDU, SGI)

These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls: Abbott Laboratories (NYSE: ABT) Cut to Sell at Citigroup. Aeropostale (NYSE: ARO) Raised to Neutral at Piper Jaffray

Tags: , , , , , , , , , , , ,

No Comments

Unusual Options Trading Alerts (AAPL, GOOG, AMZN, RIMM, GLD, BIIB, MU)

We have compiled several options chains we are watching today now that the DEC-2009 PUTS/CALLS have expired on Friday.  Much of this likely options roll-outs continuing, but we are seeing some unusual options trading in several key names above and beyond just the most active options contracts on the CBOE.  We have more detailed volume [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Tags: , , , , , , , , , , , , , ,

No Comments

BioTech Hostile Takeover: Biogen Plays For Facet

Facet Biotech Corporation (FACT) confirms that it is in receipt of Biogen Idec Inc.’s (BIIB) letter dated September 4, 2009 offering $14.50 per share for all of the outstanding shares of Facet. Facet shares rocketed 75% to $15.75 after being halted briefly. So far this year, Facet’s shares have traded as low as $6 and as [[ This is a content summary only.

Tags: , , , , , , , ,

No Comments

Biotech Business Daily (BIIB, VRTX, ALNY, STEM)

Here are some of the top stories affecting key drug and biotech stocks this Friday.  We also have links through to more detailed coverage and analysis over at BioHealthInvestor.com: Biogen Idec Inc. (Nasdaq: BIIB) kicks off the earnings season for the large biotech companies next week. We have a full earnings preview with current expectations and [[ This is a content summary only.

Tags: , , , , , , ,

No Comments

GM CFO Outlines IPO Timeline… Or Re-IPO (GMGMQ, GM)

Everyone wants to know when an initial public offering of General Motors (GMGMQ) will occur.  This emergence from bankruptcy has only expedited the curiosity of when the company will be public again.  GM’s new CFO Ray Young just gave a rather lengthy CNBC interview and this was among the issues discussed. Young said in this interview [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Tags: , , , , , , ,

No Comments

Consumer Sentiment Heading The Wrong Way

The University of Michigan has reported its preliminary consumer sentiment report for July.  It seems that the “confidence” portion may be limping back towards impotence.  The mid-July report showed a reading of 64.6, down from a consensus estimate of 70 from Bloomberg and down from 70.8 in June. The current index was at 70.4, down from [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Tags: , , , , , , ,

No Comments

Media Digest 6/5/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   Rio Tinto (RTP) has killed a deal with Chinalco for one with BHP (BHP).

Tags: , , , , , , , , , , , , ,

No Comments